Trial intelligence / Profile preview

G6PD Assessment Before Primaquine for Vivax Malaria

NCT02876549Phase 4Completed

Sponsor
University of Oxford
Start
Sep 2016
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of primaquine in Plasmodium vivax malaria, sponsored by University of Oxford. Started Sep 2016; status: completed.

02

Drugs

primaquine
03

Conditions

Plasmodium vivax malaria

Beyond the preview

Go deeper on NCT02876549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02876549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call